![Thomas Kotarakos](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Kotarakos
Director of Finance/CFO at
PARABILIS MEDICINES, INC.
Net worth: - $ as of 31/05/2026
Profile
Thomas Kotarakos is Chief Financial Officer at Parabilis Medicines, Inc. starting in 2026.
Formerly, Mr. Kotarakos was Controller at Seres Therapeutics, Inc. from 2014 to 2018 and Senior VP-Finance & Business Operations at Codiak BioSciences, Inc. from 2018 to 2021.
Education includes undergraduate and graduate degrees from Bentley University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 10/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Thomas Kotarakos active positions
| Companies | Position | Start |
|---|---|---|
| PARABILIS MEDICINES, INC. | Director of Finance/CFO | 10/12/2021 |
Former positions of Thomas Kotarakos
| Companies | Position | End |
|---|---|---|
| CODIAK BIOSCIENCES | Corporate Officer/Principal | 01/12/2021 |
| SERES THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01/10/2018 |
Training of Thomas Kotarakos
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
24
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Bentley University
 Bentley University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Seres Therapeutics, Inc.
 Seres Therapeutics, Inc. BiotechnologyHealth Technology Develops novel treatments for diseases related to the human microbiome | Health Technology |
Parabilis Medicines
 Parabilis Medicines Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops medicines for cancers and tumors | Health Technology |
Codiak BioSciences, Inc.
 Codiak BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops exosome based therapeutics | Health Technology |
- Stock Market
- Insiders
- Thomas Kotarakos
Choose MarketScreener 
